FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034784925> ?p ?o ?g. }

• W2034784925 endingPage "697" @default.
• W2034784925 startingPage "691" @default.
• W2034784925 abstract "Patients with increased triglyceride levels compared to those with normal levels are at higher risk for coronary heart disease. In patients with severe (≥500 mg/dl) hypertriglyceridemia (SHTG), clinical trials have demonstrated that prescription ω-3 fatty acids (P-OM3s) 4 g/day can decrease triglyceride levels by 45%. However, the precise health and economic benefits of decreasing SHTG with P-OM3 are unknown. We used the previously validated Archimedes model to simulate a 20-year trial involving subjects 45 to 75 years old with SHTG. The trial consisted of an intervention arm (P-OM3 4 g/day) and a control arm. Simulation results for the control arm indicated that subjects with SHTG are at about 2 times higher risk for myocardial infarction than those with normal triglyceride levels. Using estimates from previous epidemiologic studies and meta-analyses with OM3s, the model predicted 29% to 36% decreases in various measurements of adverse cardiac events for the intervention arm. The model also predicted a decrease in ischemic stroke of 24% (95% confidence interval 15 to 33). For the 20-year simulated trial, the cost per quality-adjusted life-year gained for the currently available P-OM3 approved by the Food and Drug Administration was $47,000. Results remained robust under different clinical assumptions. In our model P-OM3 was effective in decreasing triglyceride levels and cardiovascular disease risk in patients with SHTG. In conclusion, P-OM3 medication is cost effective in our simulated trial and comparable to other cost-effective cardiovascular interventions. Patients with increased triglyceride levels compared to those with normal levels are at higher risk for coronary heart disease. In patients with severe (≥500 mg/dl) hypertriglyceridemia (SHTG), clinical trials have demonstrated that prescription ω-3 fatty acids (P-OM3s) 4 g/day can decrease triglyceride levels by 45%. However, the precise health and economic benefits of decreasing SHTG with P-OM3 are unknown. We used the previously validated Archimedes model to simulate a 20-year trial involving subjects 45 to 75 years old with SHTG. The trial consisted of an intervention arm (P-OM3 4 g/day) and a control arm. Simulation results for the control arm indicated that subjects with SHTG are at about 2 times higher risk for myocardial infarction than those with normal triglyceride levels. Using estimates from previous epidemiologic studies and meta-analyses with OM3s, the model predicted 29% to 36% decreases in various measurements of adverse cardiac events for the intervention arm. The model also predicted a decrease in ischemic stroke of 24% (95% confidence interval 15 to 33). For the 20-year simulated trial, the cost per quality-adjusted life-year gained for the currently available P-OM3 approved by the Food and Drug Administration was $47,000. Results remained robust under different clinical assumptions. In our model P-OM3 was effective in decreasing triglyceride levels and cardiovascular disease risk in patients with SHTG. In conclusion, P-OM3 medication is cost effective in our simulated trial and comparable to other cost-effective cardiovascular interventions." @default.
• W2034784925 created "2016-06-24" @default.
• W2034784925 creator A5003973448 @default.
• W2034784925 creator A5010155153 @default.
• W2034784925 creator A5020057128 @default.
• W2034784925 creator A5030781214 @default.
• W2034784925 creator A5036954718 @default.
• W2034784925 creator A5056907611 @default.
• W2034784925 creator A5075486354 @default.
• W2034784925 creator A5084230583 @default.
• W2034784925 date "2011-09-01" @default.
• W2034784925 modified "2023-09-23" @default.
• W2034784925 title "Estimating Health and Economic Benefits from Using Prescription Omega-3 Fatty Acids in Patients With Severe Hypertriglyceridemia" @default.
• W2034784925 cites W1518563622 @default.
• W2034784925 cites W1872166996 @default.
• W2034784925 cites W1926170255 @default.
• W2034784925 cites W1966039186 @default.
• W2034784925 cites W1997046781 @default.
• W2034784925 cites W2005713486 @default.
• W2034784925 cites W2014696483 @default.
• W2034784925 cites W2015254695 @default.
• W2034784925 cites W2026002591 @default.
• W2034784925 cites W2052264489 @default.
• W2034784925 cites W2057947558 @default.
• W2034784925 cites W2060050759 @default.
• W2034784925 cites W2061482173 @default.
• W2034784925 cites W2098705946 @default.
• W2034784925 cites W2101328789 @default.
• W2034784925 cites W2104049876 @default.
• W2034784925 cites W2106620061 @default.
• W2034784925 cites W2121653729 @default.
• W2034784925 cites W2127448855 @default.
• W2034784925 cites W2135815454 @default.
• W2034784925 cites W2142347023 @default.
• W2034784925 cites W2146865158 @default.
• W2034784925 cites W2155365997 @default.
• W2034784925 cites W2192223169 @default.
• W2034784925 cites W4244896304 @default.
• W2034784925 doi "https://doi.org/10.1016/j.amjcard.2011.04.019" @default.
• W2034784925 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21840433" @default.
• W2034784925 hasPublicationYear "2011" @default.
• W2034784925 type Work @default.
• W2034784925 sameAs 2034784925 @default.
• W2034784925 citedByCount "14" @default.
• W2034784925 countsByYear W20347849252012 @default.
• W2034784925 countsByYear W20347849252013 @default.
• W2034784925 countsByYear W20347849252014 @default.
• W2034784925 countsByYear W20347849252015 @default.
• W2034784925 countsByYear W20347849252016 @default.
• W2034784925 countsByYear W20347849252019 @default.
• W2034784925 countsByYear W20347849252020 @default.
• W2034784925 countsByYear W20347849252022 @default.
• W2034784925 crossrefType "journal-article" @default.
• W2034784925 hasAuthorship W2034784925A5003973448 @default.
• W2034784925 hasAuthorship W2034784925A5010155153 @default.
• W2034784925 hasAuthorship W2034784925A5020057128 @default.
• W2034784925 hasAuthorship W2034784925A5030781214 @default.
• W2034784925 hasAuthorship W2034784925A5036954718 @default.
• W2034784925 hasAuthorship W2034784925A5056907611 @default.
• W2034784925 hasAuthorship W2034784925A5075486354 @default.
• W2034784925 hasAuthorship W2034784925A5084230583 @default.
• W2034784925 hasConcept C126322002 @default.
• W2034784925 hasConcept C164705383 @default.
• W2034784925 hasConcept C168563851 @default.
• W2034784925 hasConcept C2426938 @default.
• W2034784925 hasConcept C2776919658 @default.
• W2034784925 hasConcept C2778163477 @default.
• W2034784925 hasConcept C2778913445 @default.
• W2034784925 hasConcept C44249647 @default.
• W2034784925 hasConcept C500558357 @default.
• W2034784925 hasConcept C535046627 @default.
• W2034784925 hasConcept C71924100 @default.
• W2034784925 hasConcept C98274493 @default.
• W2034784925 hasConceptScore W2034784925C126322002 @default.
• W2034784925 hasConceptScore W2034784925C164705383 @default.
• W2034784925 hasConceptScore W2034784925C168563851 @default.
• W2034784925 hasConceptScore W2034784925C2426938 @default.
• W2034784925 hasConceptScore W2034784925C2776919658 @default.
• W2034784925 hasConceptScore W2034784925C2778163477 @default.
• W2034784925 hasConceptScore W2034784925C2778913445 @default.
• W2034784925 hasConceptScore W2034784925C44249647 @default.
• W2034784925 hasConceptScore W2034784925C500558357 @default.
• W2034784925 hasConceptScore W2034784925C535046627 @default.
• W2034784925 hasConceptScore W2034784925C71924100 @default.
• W2034784925 hasConceptScore W2034784925C98274493 @default.
• W2034784925 hasIssue "5" @default.
• W2034784925 hasLocation W20347849251 @default.
• W2034784925 hasLocation W20347849252 @default.
• W2034784925 hasOpenAccess W2034784925 @default.
• W2034784925 hasPrimaryLocation W20347849251 @default.
• W2034784925 hasRelatedWork W1991988227 @default.
• W2034784925 hasRelatedWork W1994077120 @default.
• W2034784925 hasRelatedWork W2005022918 @default.
• W2034784925 hasRelatedWork W2026021043 @default.
• W2034784925 hasRelatedWork W2076036291 @default.
• W2034784925 hasRelatedWork W2078150734 @default.
• W2034784925 hasRelatedWork W2094693587 @default.
• W2034784925 hasRelatedWork W2099385407 @default.

• next